Federal regulatory agencies

Federal regulatory agencies

Access to therapeutic products: the regulatory process in Canada

Text Size: Normal / Medium / Large
Resource Language: 
English
Translated Title: 
L'accès aux produits thérapeutiques: le processus de réglementation au Canada
Media Type: 
Online
Publisher: 
Health Canada
Publication Date: 
2006

Explains how drugs and other therapeutic products are regulated by the Health Products and Food Branch of Health Canada.

Available From: 
Order Information: 
Contact their office to order a copy. Also available online.
ISBN/ISSN: 
ISBN: 0-662-49101-7

Disease mongering in drug promotion: do governments have a regulatory role?

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Barbara Mintzes
Publisher: 
PLoS Medicine
Publication Date: 
2006
Publication Place: 
San Francisco, CA

Examines activities financed by drug companies to promote sales by expanding the pool of patients potentially treated by their products, when no benefit in terms of reduced morbidity is likely.

Available From: 
ISBN/ISSN: 
ISSN 15491277 (print)
ISSN 15491676 (online)
Notes: 
Includes bibliographical references.

Transparency and the drug approval process at Health Canada

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Online
Author: 
Ann Silversides
Publisher: 
Women and Health Protection
Publication Date: 
2005
Publication Place: 
Toronto, ON

Argues that the federal government is protecting drug companies instead of the public by keeping information about the drug approval process secret. Examines the impact of this on women's health.

Available From: 
ISBN/ISSN: 
WHP PHAR.S55 2005
Notes: 
Includes bibliographical references.

Transparency and the drug approval process at Health Canada: policy brief

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Paper
Online
Author: 
Women and Health Protection
Publisher: 
Women and Health Protection
Publication Date: 
2006
Publication Place: 
Toronto, ON

Argues that the lack of transparency in the drug approval process can lead to inappropriate, unnecessary and sometimes dangerous drug use, and it impedes the development of knowledge and appropriate decision-making.

Available From: 

Same tune, different lyrics: the Vioxx story

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Women and Health Protection (WHP)
Media Type: 
Paper
Online
Author: 
Anne Rochon Ford
Publisher: 
Network/Le Réseau
Publication Date: 
2005
Publication Place: 
Winnipeg, MB

Illustrates the flaws in the Canadian drug approval and drug regulatory processes, using the current Vioxx scandal as example.

ISBN/ISSN: 
ISSN 14800039

Depo-Provera and bone mineral density

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Author: 
National Women's Health Network
Publisher: 
National Women's Health Network
Publication Date: 
2005
Publication Place: 
Washington, DC

Summarizes the findings of research on Depo-Provera's effect on bone density (2004).

Notes: 
Includes bibliographical references.

Significant bone loss associated with Depo-Provera use is sadly no surprise; we call for action to make sure this doesn't happen

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Publisher: 
Canadian Women's Health Network
Publication Date: 
2004
Publication Place: 
Winnipeg, MB

Discusses the debate surrounding Depo-Provera's approval for contraception use in 1997 when women's groups had already highlighted it's impact on bone mineral density.

Drug regulatory failure in Canada: the case of Diane-35

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Paper
Online
Author: 
Barbara Mintzes
Publisher: 
Women and Health Protection
Publication Date: 
2004
Publication Place: 
Toronto, ON

Criticizes federal prescription drug regulation using Diane-35 (cyproterone acetate and ethinyl estradiol) as an example.

ISBN/ISSN: 
ISBN 097331172X
WHP HEAP.M56 2004
Notes: 
Includes bibliographical references.

Public opinion survey on key issues pertaining to post-market surveillance of marketed health products in Canada: final report

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Decima Reseach Inc.
Publisher: 
Health Canada, Health Products and Food Branch, Therapeutic Products Directorate
Publication Date: 
2003
Publication Place: 
Ottawa, ON

Presents the results of a survey where Canadians were asked to give their views and opinions on the effectiveness of Health Canada's methods to communicate health product safety information.

Opening the medicine cabinet: first report on health aspects of prescription drugs: report of the Standing Committee on Health

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Bonnie Brown
Publisher: 
Communication Canada - Publishing
Publication Date: 
2004
Publication Place: 
Ottawa, ON

Provides a study of the health aspects of prescription drugs in Canada. Addresses issues relevant to prescription drugs in Canada. Includes recommendations.

Syndicate content